The separation of coatings on certain intravascular medical devices has the potential to cause serious injuries to patients, the US Food and Drug Administration (FDA) warned on Monday.
FDA is trying to make health care providers aware that patients could be at risk if the hydrophilic and/or hydrophobic coatings separate (e.g., peel, flake, shed, delaminate, slough off) from devices such as intravascular catheters, guidewires, balloon angioplasty catheters, delivery sheaths, and implant delivery systems commonly used during minimally invasive procedures in the cerebrovascular, cardiovascular and peripheral vascular systems.
The lubricious coatings -- meant to decrease the friction between the device and blood vessels -- have been used for more than 20 years on millions of patients in minimally invasive procedures, FDA says.
But the agency has not concluded that any specific manufacturer or brand of devices is associated with higher risks than others.
FDA’s Center for Devices and Radiological Health said last month that in 2016 it would further investigate new methodologies and tools that more accurately predict the clinical impact of surface coatings, materials corrosion and additive manufacturing on device quality, performance and safety.
Since 1 January 2014, FDA has received about 500 medical device reports (MDRs) on the coating separations, including 11 that described patient deaths.
Of the 11 patient deaths from the MDRs, FDA notes that two of those weren’t attributed to the device coating, but the other nine described in the medical literature noted that “occlusion of blood vessels reportedly occurred due to embolization of coating particles from devices during heart and brain catheterization procedures contributing to clinical adverse events such as heart attack and bleeding inside the brain.”
FDA also warns: “It may be difficult for clinicians to associate these adverse events with malfunction of the coating; instead, they may mistakenly attribute the adverse events to other procedural complications or patient co-morbidities.”
Since 1 January 2010, FDA also says there have been 11 recalls linked to these device coatings peeling or flaking off.
“The majority of the recalls were associated with guidewires, but there have also been recalls for other types of devices including sheaths, retrieval devices and embolization device delivery wires used in the vasculature,” FDA says.
Since the cause of the coating separation is multifactorial, and can be associated with factors including device design, device manufacturing, and use, current FDA analysis suggests that “use-related issues may be mitigated through proper device selection, preparation, and other considerations.”
Among those other considerations are:
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.